---
company: Adient plc
ticker: ADNT
form: 8-K
filed: 2026-05-06
accession: 0001670541-26-000057
source: https://www.sec.gov/Archives/edgar/data/1670541/000167054126000057/
---

# Adient (ADNT) earnings release, May 6, 2026

Adient plc (ADNT) · Form 8-K, Item 2.02 · Filed 2026-05-06 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1670541/000167054126000057/)

Appendix

Page 1

Adient plc

Condensed Consolidated Statements of Income (Loss)

(Unaudited)

Appendix

Page 2

Adient plc

Condensed Consolidated Statements of Financial Position

(Unaudited)

Appendix

Page 3

Adient plc

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Appendix

Page 4

Footnotes

1. Segment Results

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, the Middle East and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income (loss) before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items. Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

Financial information relating to Adient's reportable segments is as follows:

Appendix

Page 5

The following is a reconciliation of Adient's reportable segments' adjusted EBITDA to income (loss) before income taxes:

Refer to the Footnote Addendum for footnote explanations.

2. Earnings (loss) Per Share

The following table reconciles the numerators and denominators used to calculate basic and diluted income (loss) per share:

The effect of common stock equivalents which would have been anti-dilutive was excluded, and immaterial, from the calculation of diluted earnings per share for the three months ended March 31, 2026. Potentially dilutive securities whose effect would have been anti-dilutive are excluded from the computation of diluted earnings per share for the three months ended March 31, 2025 as a result of being in a loss position.

Appendix

Page 6

3. Non-GAAP Measures

Adjusted EBIT, adjusted EBIT margin, adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss) attributable to Adient, adjusted effective tax rate, adjusted earnings per share, adjusted equity income, adjusted interest expense, free cash flow, net debt, and net leverage ratio as well as other measures presented on an adjusted basis are not recognized terms under U.S. GAAP and do not purport to be alternatives to the most comparable U.S. GAAP amounts. Since all companies do not use identical calculations, our definition and presentation of these measures may not be comparable to similarly titled measures reported by other companies. Management uses the identified non-GAAP measures to evaluate the operating performance of Adient and its business segments and to forecast future periods. Management believes these non-GAAP measures assist investors and other interested parties in evaluating Adient's on-going operations and provide important supplemental information to management and investors regarding financial and business trends relating to Adient's financial condition and results of operations. Investors should not consider these non-GAAP measures as alternatives to the related GAAP measures. Reconciliations of non-GAAP measures to their closest U.S. GAAP equivalent are presented in the corresponding tables that follow the definitions below. Reconciliations of non-GAAP measures related to guidance for any future period have not been provided due to the unreasonable efforts it would take to provide such reconciliations.

Table

Appendix

Page 7

Reconciliations of non-GAAP measures to their closest US GAAP equivalent:

(a) & (b) Adjusted EBIT and Adjusted EBITDA

The following table reconciles net income (loss) to EBIT, adjusted EBIT and adjusted EBITDA:

Refer to the Footnote Addendum for footnote explanations.

Appendix

Page 8

(c) Adjusted net income attributable to Adient

The following table reconciles net income (loss) attributable to Adient to adjusted net income attributable to Adient:

Refer to the Footnote Addendum for footnote explanations.

(d) Adjusted income tax expense and effective tax rate

The following table reconciles income before income taxes to adjusted income before income taxes, reconciles income tax expense to adjusted income tax expense and presents the related effective tax rate and adjusted effective tax rate: nm - not meaningful

Appendix

Page 9

(e) Adjusted diluted earnings per share

The following table shows the calculation of diluted earnings per share on an adjusted basis:

The following table reconciles diluted earnings (loss) per share as reported to adjusted diluted earnings per share (see table (c) for corresponding dollar amounts):

(f) Adjusted equity income

The following table reconciles equity income to adjusted equity income:

Appendix

Page 10

(g) Adjusted interest expense

The following table reconciles net financing charges to adjusted net financing charges:

(h) Free cash flow

The following table reconciles cash from operating activities to free cash flow:

The following table reconciles adjusted EBITDA to free cash flow:

During the second quarter of fiscal 2026, Adient experienced higher operating cash flows resulting from certain commercial and derivative transactions approximating $90 million, which are expected to be settled and paid in the third quarter of fiscal 2026.

Appendix

Page 11

(i) & (j) Net debt and net leverage ratio

The following table presents calculations of net debt and net leverage ratio:

Appendix

Page 12

Footnote Addendum

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.... (truncated)probable and reasonably estimable and one-time asset impairments related to restructuring activities. During the three months ended March 31, 2025 a goodwill impairment charge of $333 million was recorded in EMEA.

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities:

(5) Other items include:

(6) Reflects the impact of adjustments, primarily purchase accounting amortization on noncontrolling interests.

## Financial statements

### Income Statement (Three Months Ended March 31, — (Unaudited) (in millions, except per share data))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Net sales | 3,865 | 3,611 |
| Cost of sales | 3,608 | 3,350 |
| Gross profit | 257 | 261 |
| Selling, general and administrative expenses | 138 | 144 |
| Restructuring and impairment costs | 5 | 351 |
| Equity income | 13 | 18 |
| Earnings (loss) before interest and income taxes | 127 | -216 |
| Net financing charges | 48 | 48 |
| Other pension expense | 3 | 1 |
| Income (loss) before income taxes | 76 | -265 |
| Income tax provision | 32 | 48 |
| Net income (loss) | 44 | -313 |
| Income attributable to noncontrolling interests | 17 | 22 |
| Net income (loss) attributable to Adient | 27 | -335 |
| Diluted earnings (loss) per share | 0.34 | -3.99 |
| Shares outstanding at period end | 78.4 | 84 |
| Diluted weighted average shares | 79.3 | 84 |

### Income Statement (Three Months Ended March 31, — The following table reconciles net income (loss) to EBIT, adjusted EBIT and adjusted EBITDA: (in millions))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Net income (loss) | 44 | -313 |
| Net financing charges | 48 | 48 |
| Other pension expense | 3 | 1 |
| Income tax expense | 32 | 48 |
| Earnings (loss) before interest and income taxes (EBIT) | 127 | -216 |
| EBIT adjustments: | Restructuring and impairment costs (2) | 5 | 351 |
| EBIT adjustments: | Purchase accounting amortization (3) | 12 | 12 |
| EBIT adjustments: | Restructuring related activities (4) | 6 | 5 |
| EBIT adjustments: | Other items (5) | -4 | 9 |
| EBIT adjustments: | EBIT adjustments total | 19 | 377 |
| EBIT adjustments: | Adjusted EBIT | 146 | 161 |
| EBITDA adjustments: | Depreciation | 68 | 67 |
| EBITDA adjustments: | Equity based compensation | 9 | 5 |
| EBITDA adjustments: | Adjusted EBITDA | 223 | 233 |
| EBITDA adjustments: | Net sales | 3,865 | 3,611 |
| EBITDA adjustments: | Net income (loss) as % of net sales | 1.1 | -8.7 |
| EBITDA adjustments: | EBIT as % of net sales | 3.3 | -6 |
| EBITDA adjustments: | Adjusted EBIT as % of net sales | 3.8 | 4.5 |
| EBITDA adjustments: | Adjusted EBITDA as % of net sales | 5.8 | 6.5 |

### Income Statement (Three Months Ended March 31, — The following table shows the calculation of diluted earnings per share on an adjusted basis: (in millions, except per share data))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Adjusted net income attributable to Adient - see table (c) | 41 | 58 |
| Denominator: | Basic weighted average shares outstanding | 78.4 | 84 |
| Effect of dilutive securities: | Unvested restricted stock and unvested performance share awards | 0.9 | 0.1 |
| Effect of dilutive securities: | Diluted weighted average shares outstanding | 79.3 | 84.1 |
| Effect of dilutive securities: | Adjusted diluted earnings per share | 0.52 | 0.69 |

### Income Statement (Three Months Ended March 31,)

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Diluted earnings (loss) per share as reported | 0.34 | -3.99 |
| EBIT adjustments total | 0.24 | 4.49 |
| Tax impact of EBIT adjustments and other tax items | -0.08 | 0.18 |
| Pension actuarial loss | 0.03 |  |
| Write off of deferred financing costs upon repurchase of debt |  | 0.02 |
| Impact of adjustments on noncontrolling interests | -0.01 | -0.01 |
| Adjusted diluted earnings per share | 0.52 | 0.69 |

### Balance Sheet (September 30, — (Unaudited) (in millions))

| | March 31, – 2026 | September 30, – 2025 |
|---|---:|---:|
| Cash and cash equivalents | 831 | 958 |
| Accounts receivable - net | 2,032 | 1,873 |
| Inventories | 735 | 695 |
| Other current assets | 649 | 607 |
| Current assets | 4,247 | 4,133 |
| Property, plant and equipment - net | 1,384 | 1,409 |
| Goodwill | 1,798 | 1,807 |
| Other intangible assets - net | 305 | 319 |
| Investments in partially-owned affiliates | 301 | 276 |
| Assets held for sale | 12 | 9 |
| Other noncurrent assets | 985 | 1,001 |
| Total assets | 9,032 | 8,954 |
| Liabilities and Shareholders' Equity | Short-term debt | 9 | 11 |
| Liabilities and Shareholders' Equity | Accounts payable and accrued expenses | 3,113 | 2,942 |
| Liabilities and Shareholders' Equity | Other current liabilities | 748 | 734 |
| Liabilities and Shareholders' Equity | Current liabilities | 3,870 | 3,687 |
| Liabilities and Shareholders' Equity | Long-term debt | 2,379 | 2,386 |
| Liabilities and Shareholders' Equity | Other noncurrent liabilities | 695 | 723 |
| Liabilities and Shareholders' Equity | Redeemable noncontrolling interests | 71 | 95 |
| Liabilities and Shareholders' Equity | Shareholders' equity attributable to Adient | 1,713 | 1,766 |
| Liabilities and Shareholders' Equity | Noncontrolling interests | 304 | 297 |
| Liabilities and Shareholders' Equity | Total liabilities and shareholders' equity | 9,032 | 8,954 |

### Cash Flow (Three Months Ended March 31, — (Unaudited) (in millions))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Net income (loss) attributable to Adient | 27 | -335 |
| Income attributable to noncontrolling interests | 17 | 22 |
| Net income (loss) | 44 | -313 |
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | Depreciation | 68 | 67 |
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | Amortization of intangibles | 12 | 12 |
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | Pension and postretirement benefit expense | 5 | 3 |
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | Pension and postretirement contributions, net | -8 | -5 |
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | Equity in earnings of partially-owned affiliates, net of dividends received | 15 | 29 |
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | Deferred income taxes | 1 | 10 |
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | Non-cash impairment charges |  | 333 |
